Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enavogliflozin + metformin vs dapagliflozin + metformin in type 2 diabetes mellitus uncontrolled on metformin
CTR20221776Phase 3Completed
- Sponsor
- Daewoong Pharmaceutical
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of enavogliflozin in type 2 diabetes mellitus (T2DM), sponsored by Daewoong Pharmaceutical. Started Jul 2022; status: completed.
02
Drugs
enavogliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20221776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221776.